Jul 28, 2021

Long COVID: Symptoms experienced during infection may predict lasting illness

JAKOB HC HERO TEMPLATE (2)

However, as time has passed, it’s become clear that some people, regardless of the severity of their disease, continue to experience symptoms beyond the acute phase of infection. This has become known as “long COVID”.

Emerging evidence suggests that these patients experience a range of persistent symptoms and health complications. These may have a significant impact on their quality of life, physical and mental health, and ability to return to work.

But understanding long COVID is difficult. Its reported symptoms are highly varied, making it difficult to define. Many sufferers also weren’t hospitalised during the acute phase of their infection, and so weren’t tested for the coronavirus during the first wave of the pandemic. This makes it more difficult to understand what the potential causes of their long-lasting symptoms are, and also how these relate to symptoms that patients had during the early stages of infection.

We and other researchers from the Therapies for Long COVID (TLC) Study Group at the University of Birmingham therefore decided to try to build a clearer picture of what long COVID is and what influences it by pooling data from lots of separate studies. This gave us a view of the prevalence of reported symptoms, and better allowed us to see what the impacts and complications of long COVID are. Here’s what we discovered.

Symptoms of long COVID

Our review showed just how varied long COVID is. Patients may experience symptoms related to any system in the body – including respiratory, neurological and gastroenterological symptoms. Our pooled data showed that the ten most commonly reported symptoms in long COVID are fatigue, shortness of breath, muscle pain, cough, headache, joint pain, chest pain, an altered sense of smell, diarrhoea and altered taste.

Other common symptoms include “brain fog” – when thinking is fuzzy and sluggish – memory loss, disordered sleep, heart palpitations and a sore throat. Rare but important outcomes include thoughts of self-harm and suicide and even seizures.

Most long COVID patients complain of symptoms experienced during their acute infection persisting beyond it, with the number of symptoms experienced tending to decline as patients move from acute to long COVID. Some, though, report developing new symptoms during their long COVID illness, while some also report symptoms reoccuring that had previously resolved themselves.

One of the studies we included in our review described two main symptom clusters of long COVID: those comprising exclusively of fatigue, headache and upper respiratory complaints; and those that are multi-system complaints, including ongoing fever and gastroenterological symptoms. This division encapsulates the difficulty of trying to pin long COVID down – it is a wide-ranging condition containing many types of complaints.

The mid-term and long-term effects and impacts of long COVID are yet to be fully understood. However, the evidence we reviewed suggests that people with long COVID may experience significant reductions in their quality of life, difficulties carrying out their daily activities or returning to full-time employment, as well as mental health issues.

One study reported that nearly a quarter of previously hospitalised COVID-19 patients suffered from anxiety or depression six months after the onset of their symptoms. People with long COVID often report being dismissed by healthcare professionals and receiving little or no support for the management of their condition – underlining the need for better treatments.

What increases the likelihood of long COVID?

We found that a range of factors are associated with developing long COVID. For instance, one study reported that the presence of more than five symptoms of COVID-19 in the first week of infection was significantly associated with developing long COVID, irrespective of age or gender.

In addition, being older, female and hospitalised at symptom onset were found to be significantly associated with an increased risk of developing long COVID. However, several studies showed that for a significant number of patients, developing long COVID didn’t seem to be tied to the severity of their initial illness.

Experiencing certain symptoms during the acute phase of infection – such as initial breathlessness, chest pain or abnormal heart sounds – was also strongly associated with developing long-lasting symptoms. Having co-morbidities, particularly asthma, also raised the risk.

What the huge variability of long COVID suggests is that it actually comprises a number of different syndromes, potentially with different underlying causes. A better understanding of the underlying biological and immunological mechanisms of long COVID is therefore urgently needed if we’re to develop effective treatments for it.

The impacts that patients report – on their lives, work and mental health – make it clear that better ways of caring for people with long COVID patients are urgently needed. As well as evaluating symptoms and investigating the underlying mechanisms of long COVID, our TLC Study Group was set up to identify potential interventions for treating long COVID that could be evaluated in clinical trials. Armed with the knowledge from this research, this is what we’re aiming to work towards next.The Conversation

Olalekan Lee Aiyegbusi, Research Fellow, Institute of Applied Health Research, University of Birmingham and Shamil Haroon, Academic Clinical Lecturer, Institute of Applied Health Research, University of Birmingham

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. When you read the information in articles such as this, it does make you wonder about the rationality of those people who are prepared to either not be vaccinated, or delay vaccination until they can receive the vaccine of their choice. The acute phase of the illness with the current predominant strain is frightening enough, let alone the potential to develop life long illness and potential disability.

  2. This research needs to shared, so doctors don’t brush patients off and take them seriously.

    Following pneumonia in Apr 19 I have had very similar issues. Just couldn’t shake off the coughing and just not being 100%.

    Jan 20 I became very tired and hit the wall.
    Aug 20 I was diagnosed with narcolepsy, which has stopped me working as a high functioning manager. Round this time my liver blood tests had had gone up substantially for no reason, prior they were normal.
    Feb 21 I was diagnosed with stage 3 NASH for which there is no treatment just management and fingers crossed.

    All from a common infection/virus, prior to this as a 55 yr old, I didn’t have any health issues.

    I was so lucky my GP listened to me and kept investigating. I still find it hard to believe.

    Unfortunately 1st line treatment is often antidepressants as many patients are diagnosed with depression and anxiety, this maybe part of it but what else is going on.

    I work in the medical industry, I was beginning to doubt myself after seeing A-Z specialist who in the start couldn’t come up with anything other than maybe secondary virus’s.

Banner Banner
Advertisement
Banner Banner
Advertisement

Former aged care worker pleads guilty to stealing $132,000 from resident

Former aged care worker Kaylene Joy Stanborough pleads guilty to stealing $132,000 from resident after entering joint power of attorney for the 89 year old. Read More

Long-term antibiotic use potentially linked to higher cancer risk

Most people have had antibiotics at some point in their life – whether it be to help combat a virus or an infection. But some people have conditions that require them to take long courses of antibiotics. And new research has found that long term antibiotic use may increase the risk of having certain types... Read More

Embedded pharmacist best practice for medicine safety, says peak body

A pharmacists’ peak body has described Goodwin’s residential care pharmacist role a best-practice example, as aged care consumers share feedback on its first year in action. Aged care consumers shared positive experiences of Australia’s first embedded residential care pharmacist at the launch of the Pharmaceutical Society of Australia’s annual Medicine Safety: Aged Care report.  Medicine... Read More
Banner Banner
Advertisement